Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide notice appears above the page, announcing an NIH website transition and saying that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T14:01:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov version as v3.7.2 instead of v3.7.1. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:36:06.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:24:43.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, indicating access to the NCT03463681 entry is blocked. The site chrome (header, navigation, and footer) remains visible, signaling a site-level access problem rather than updated study content.
    Difference
    17%
    Check dated 2026-09-21T21:51:54.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, indicating a newer software revision has been applied.
    Difference
    0.1%
    Check dated 2026-08-31T17:41:08.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new line '2018 ( U.S. NIH Grant/Contract )' was added under the Other Study ID Numbers, indicating NIH grant support for the study.
    Difference
    0.1%
    Check dated 2026-08-24T16:33:33.000Z thumbnail image

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.